SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNLX - NanoLogix, Incorporated
NNLX 0.00010000.0%Oct 20 10:06 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: kphone8/15/2012 7:59:37 PM
  Read Replies (1) of 78
 
Nanologix "Great News"

I have been waiting for this, for a long time.

NanoLogix is pleased to announce that the company will begin commercial marketing of its BNP (BioNanoPore) and BNF (BioNanoFilter) diagnostic kits under FDA 510K-exempt status."

So call it 'FDA 510k-exempt status" or call it "FDA Approved", my understanding is that they have FDA authorization to market - SELL BNP and BNF kits and Petri Plates!

nanologix.com

Watch the stock move up within the next few days, give it 60 to 120 days for $5 plus!

GLTA Longs

Ken
In Raleigh
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext